Integration of 5-ALA Fluorescence Lifetime Imaging with Stereotactic Surgical Navigation for Quantitative Real-Time Spatial Localization of Tumor During Neurosurgical Procedures

5-ALA 荧光寿命成像与立体定向手术导航相结合，用于神经外科手术过程中肿瘤的定量实时空间定位

• 批准号: 10578584
• 负责人: Orin Bloch
• 金额: $ 59.03万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-01-01 至 2027-12-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10578584
• 关键词: Acids; Adjuvant; Adopted; Aminolevulinic Acid; Anatomy; Area; Augmented Reality; Biopsy; Brain; Brain Neoplasms; Brain region; Clinical; Clinical Research; Computer software; Correlation Studies; Darkness; Data; Data Display; Detection; Disease; Emerging Technologies; Excision; FDA approved; Fiber; Fluorescence; Glioblastoma; Goals; Image; Imaging Device; Imaging technology; Infiltration; Light; Lighting; Location; Magnetic Resonance Imaging; Malignant Neoplasms; Malignant neoplasm of brain; Manufacturer; Measurement; Measures; Metabolism; Methods; Microinvasive; Microscope; Monitor; Nature; Neuronavigation; Neurosurgical Procedures; Newly Diagnosed; Normal tissue morphology; Operative Surgical Procedures; Optics; Patient imaging; Patients; Pharmaceutical Preparations; Physiologic pulse; Positioning Attribute; Postoperative Period; Process; Prognosis; Prospective Studies; Real-Time Systems; Resectable; Resected; Residual Neoplasm; Sampling; Scanning; Signal Transduction; Surface; Surgeon; Surgical margins; Surgically-Created Resection Cavity; System; Techniques; Technology; Time; Tissues; Tumor Burden; Tumor Tissue; Visual; Visualization; Work; brain based; brain tumor resection; clinical application; clinically significant; fluorescence imaging; fluorescence lifetime imaging; fluorescence-guided surgery; imaging system; improved; neoplastic cell; neurosurgery; novel; optical imaging; prospective; protoporphyrin IX; radiological imaging; software development; spatial integration; tool; tumor; virtual

PROJECT SUMMARY/ABSTRACT Maximal surgical resection of the most common primary brain cancer, glioblastoma (GBM), has been shown to improve overall survival in a highly morbid disease. However, delineation of residual tumor at the margins of surgical resections can be challenging using conventional techniques, and therefore the use of fluorescence guided surgery (FGS) has emerged as an adjuvant tool for tumor detection. At present, only one agent, 5- aminoleveulinic acid (5-ALA), is approved for detection of GBM during surgery. Metabolism of 5-ALA into protoporphyrin IX (PpIX) is detected qualitatively by wide-field fluorescence imaging through the surgical microscope. This intensity-based detection is non-quantitative and background light-sensitive, requiring the surgeon to work in a dark field. We have developed a fiber-based pulse-excitation time-resolved method for Fluorescence Lifetime Imaging (FLIm) to detect quantitative PpIX fluorescence in real-time under full illumination conditions. Our goal in this study is to integrate the point-scanning FLIm technology with an existing intraoperative stereotactic neuronavigation system produced by BrainLab to spatially co-register FLIm data across the surgical field for applicable surgical guidance. We aim to develop new software and tissue classifiers based on primary patient data, and to apply the integrated technology in a prospective clinical study to demonstrate the benefits for surgical navigation. To achieve the overall goal of developing a new integrated technology which is immediately applicable for routine use in brain tumor resections, we will undertake the following aims: Aim 1) To develop new software for integration of the FLIm device with the BrainLab neuronavigation system for real-time acquisition of spatial positioning of FLIm data and display of the data overlaid on the patient’s imaging in the navigation space. Aim 2) To develop classifiers for surgically resectable tumor based on PpIX fluorescence lifetime thresholds determined through a prospective study correlating FLIm data to tissue biopsies. Aim 3) To validate the accuracy of integrated FLIm-based navigation in identifying residual tumor tissue to facilitate a greater extent of resection in a prospective clinical study.

项目概要/摘要 最常见的原发性脑癌胶质母细胞瘤 (GBM) 的最大手术切除已被证明 提高高发病率疾病的总体生存率然而，在边缘处描绘残留肿瘤。 使用传统技术进行手术切除可能具有挑战性，因此使用荧光 引导手术（FGS）已成为肿瘤检测的辅助工具，目前只有一种药物，5-。 氨基乙酰丙酸 (5-ALA) 被批准用于手术期间检测 GBM 5-ALA 代谢成的物质。 原卟啉 IX (PpIX) 通过手术中的广域荧光成像进行定性检测 这种基于强度的检测是非定量的并且对背景光敏感，需要 我们开发了一种基于光纤的脉冲激励时间分辨方法。 荧光寿命成像 (FLIm) 可在全光条件下实时检测定量 PpIX 荧光 我们在这项研究中的目标是将点扫描 FLIm 技术与 BrainLab 生产的现有术中立体定向神经导航系统可在空间上共同配准 FLIm 我们的目标是开发新的软件和组织。 基于原始患者数据的分类器，并将集成技术应用于前瞻性临床研究 展示手术导航的好处。 实现开发可立即应用的新型集成技术的总体目标 为了在脑肿瘤切除术中常规使用，我们将实现以下目标： 目标 1) 开发新的软件 FLIm 设备与 BrainLab 神经导航系统集成，用于实时采集空间信息 FLIm 数据的定位以及在导航空间中叠加在患者成像上的数据显示。 2）开发基于PpIX荧光寿命阈值的可手术切除肿瘤的分类器 通过将 FLIm 数据与组织活检相关联的前瞻性研究确定 目标 3) 验证 基于 FLIm 的集成导航在识别残留肿瘤组织方面的准确性，以促进更大范围的治疗 前瞻性临床研究中的切除术。